Bae; Myung-Ae

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bae; Myung-Ae.The latest application filed is for "novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient".

Company Profile

1.11.9

Bae; Myung-Ae - Daejeon KR
Bae; Myung Ae - Yuseong-gu KR
Bae; Myung Ae - Taejeon-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient Grant 9,321,728 - Ahn , et al. April 26, 2	2016-04-26
Novel Beta-alanine Derivatives, Pharmaceutically Acceptable Salts Thereof, And Pharmaceutical Composition Comprising Same As Active Ingredient App 20150329504 - AHN; Jin Hee ; et al.	2015-11-19
Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative Grant 9,090,608 - Kim , et al. July 28, 2	2015-07-28
Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt Grant 9,073,906 - Kim , et al. July 7, 2	2015-07-07
Indenone derivative and pharmaceutical composition comprising same Grant 8,877,747 - Heo , et al. November 4, 2	2014-11-04
Method for the treatment of bone diseases comprising colforsin daropate Grant 8,865,762 - Kwon , et al. October 21, 2	2014-10-21
Sulfamide Derivative Having An Adamantyl Group And Its Pharmaceutically Acceptable Salt App 20140024636 - Kim; Ki Young ; et al.	2014-01-23
Pharmaceutical Composition For Preventing Or Treating Osteoporosis Or Obesity Comprising Phenyltetrazole Derivative App 20130123297 - KIM; Nak Jeong ; et al.	2013-05-16
Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative Grant 8,372,862 - Kim , et al. February 12, 2	2013-02-12
Indenone Derivative and Pharmaceutical Composition Comprising Same App 20120214991 - Heo; Jung Nyoung ; et al.	2012-08-23
Composition For The Prevention Or Treatment Of Bone Diseases Comprising Colforsin Daropate App 20120184604 - Kwon; Byoung Mog ; et al.	2012-07-19
7-(3',4'-Dialkoxyphenyl)[1,2,4]-triazolo[1,5-A]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same Grant 8,143,262 - Jeon , et al. March 27, 2	2012-03-27
Screening Method For The Composition For Prevention Or Treatment Of Osteoporosis And Metabolic Bone Disease Using Tallyho/jngj Mouse App 20100333217 - Bae; Myung Ae ; et al.	2010-12-30
Pharmaceutical Composition For Preventing Or Treating Osteoporosis Or Obesity Comprising Phenyltetrazole Derivative App 20100305324 - KIM; Nak Jeong ; et al.	2010-12-02
7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same App 20100105704 - Jeon; Dong Ju ; et al.	2010-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.